Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

C4 Therapeutics, Inc.

SIC 2836 · Biological Products (No Diagnostic Substances)
NotesSupport
aboutterms
$CCCC

C4 Therapeutics, Inc.

CIK:0001662579|SEC Filings

MATERIAL CONTRACTS

EX-10.2
exhibit102rochec4t.htm
Aug 11, 2026
EX-10.1#
c4t-amendment2to2020stoc.htm
Jun 24, 2026
EX-10.18
parsuagreementfebruary20.htm
Feb 26, 2026
EX-10.19
c4t-mkdgcollaborationagr.htm
Feb 27, 2025
EX-10.1
c4tfisherconsultingagree.htm
Oct 16, 2024
EX-10.1
c4tfisherconsultingagree.htm
Oct 15, 2024
EX-10.1
c4-amendment1to2020stock.htm
Oct 11, 2024
EX-10.1
a240301_c4t-mkdgcollabor.htm
May 8, 2024
EX-10.19
c4t-formofnsoagreementin.htm
Feb 22, 2024
EX-10.18
merck-c4txlicenseandcoll.htm
Feb 22, 2024
EX-10.2
projgeoffrey-stockpurchase.htm
May 30, 2023
EX-10.1
redacted-projectgeoffreyxc.htm
May 30, 2023
EX-10.2
exhibit102.htm
Feb 23, 2023
EX-10.1
cccc-ex101_7.htm
Nov 30, 2021
EX-10.11
cccc-ex1011_218.htm
Mar 11, 2021
EX-10.13
cccc-ex1013_217.htm
Mar 11, 2021
EX-10.2
d772024dex102.htm
Sep 28, 2020
EX-10.3
d772024dex103.htm
Sep 28, 2020
EX-10.10
d772024dex1010.htm
Sep 10, 2020
EX-10.11
d772024dex1011.htm
Sep 10, 2020